Global Finasteride Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Finasteride market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Finasteride include Teva Pharmaceuticals, Sandoz, Shandong Renhetang Pharmaceutical, Merck, Zhejiang CONBA Pharmaceutical, Henan Topfond, Guangdong Eashu Pharmacetical, RelonChem and Dr. Reddy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Finasteride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Finasteride, also provides the sales of main regions and countries. Of the upcoming market potential for Finasteride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Finasteride sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Finasteride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Finasteride sales, projected growth trends, production technology, application and end-user industry.
Finasteride Segment by Company
Teva Pharmaceuticals
Sandoz
Shandong Renhetang Pharmaceutical
Merck
Zhejiang CONBA Pharmaceutical
Henan Topfond
Guangdong Eashu Pharmacetical
RelonChem
Dr. Reddy
Cipla
Actavis
Accord Pharmaceuticals
Finasteride Segment by Type
1mg Tablet
5mg Tablet
Finasteride Segment by Application
Medical Uses
Application 2
Finasteride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Finasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Finasteride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Finasteride market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Finasteride include Teva Pharmaceuticals, Sandoz, Shandong Renhetang Pharmaceutical, Merck, Zhejiang CONBA Pharmaceutical, Henan Topfond, Guangdong Eashu Pharmacetical, RelonChem and Dr. Reddy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Finasteride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Finasteride, also provides the sales of main regions and countries. Of the upcoming market potential for Finasteride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Finasteride sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Finasteride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Finasteride sales, projected growth trends, production technology, application and end-user industry.
Finasteride Segment by Company
Teva Pharmaceuticals
Sandoz
Shandong Renhetang Pharmaceutical
Merck
Zhejiang CONBA Pharmaceutical
Henan Topfond
Guangdong Eashu Pharmacetical
RelonChem
Dr. Reddy
Cipla
Actavis
Accord Pharmaceuticals
Finasteride Segment by Type
1mg Tablet
5mg Tablet
Finasteride Segment by Application
Medical Uses
Application 2
Finasteride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Finasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Finasteride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
198 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Finasteride Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Finasteride Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Finasteride Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Finasteride Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Finasteride Market Dynamics
- 2.1 Finasteride Industry Trends
- 2.2 Finasteride Industry Drivers
- 2.3 Finasteride Industry Opportunities and Challenges
- 2.4 Finasteride Industry Restraints
- 3 Finasteride Market by Manufacturers
- 3.1 Global Finasteride Revenue by Manufacturers (2020-2025)
- 3.2 Global Finasteride Sales by Manufacturers (2020-2025)
- 3.3 Global Finasteride Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Finasteride Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Finasteride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Finasteride Manufacturers, Product Type & Application
- 3.7 Global Finasteride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Finasteride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Finasteride Players Market Share by Revenue in 2024
- 3.8.3 2024 Finasteride Tier 1, Tier 2, and Tier 3
- 4 Finasteride Market by Type
- 4.1 Finasteride Type Introduction
- 4.1.1 1mg Tablet
- 4.1.2 5mg Tablet
- 4.2 Global Finasteride Sales by Type
- 4.2.1 Global Finasteride Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Finasteride Sales by Type (2020-2031)
- 4.2.3 Global Finasteride Sales Market Share by Type (2020-2031)
- 4.3 Global Finasteride Revenue by Type
- 4.3.1 Global Finasteride Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Finasteride Revenue by Type (2020-2031)
- 4.3.3 Global Finasteride Revenue Market Share by Type (2020-2031)
- 5 Finasteride Market by Application
- 5.1 Finasteride Application Introduction
- 5.1.1 Medical Uses
- 5.1.2 Application 2
- 5.2 Global Finasteride Sales by Application
- 5.2.1 Global Finasteride Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Finasteride Sales by Application (2020-2031)
- 5.2.3 Global Finasteride Sales Market Share by Application (2020-2031)
- 5.3 Global Finasteride Revenue by Application
- 5.3.1 Global Finasteride Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Finasteride Revenue by Application (2020-2031)
- 5.3.3 Global Finasteride Revenue Market Share by Application (2020-2031)
- 6 Global Finasteride Sales by Region
- 6.1 Global Finasteride Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Finasteride Sales by Region (2020-2031)
- 6.2.1 Global Finasteride Sales by Region (2020-2025)
- 6.2.2 Global Finasteride Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Finasteride Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Finasteride Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Finasteride Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Finasteride Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Finasteride Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Finasteride Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Finasteride Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Finasteride Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Finasteride Revenue by Region
- 7.1 Global Finasteride Revenue by Region
- 7.1.1 Global Finasteride Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Finasteride Revenue by Region (2020-2025)
- 7.1.3 Global Finasteride Revenue by Region (2026-2031)
- 7.1.4 Global Finasteride Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Finasteride Revenue (2020-2031)
- 7.2.2 North America Finasteride Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Finasteride Revenue (2020-2031)
- 7.3.2 Europe Finasteride Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Finasteride Revenue (2020-2031)
- 7.4.2 Asia-Pacific Finasteride Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Finasteride Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Finasteride Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 Teva Pharmaceuticals
- 8.1.1 Teva Pharmaceuticals Comapny Information
- 8.1.2 Teva Pharmaceuticals Business Overview
- 8.1.3 Teva Pharmaceuticals Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 Teva Pharmaceuticals Finasteride Product Portfolio
- 8.1.5 Teva Pharmaceuticals Recent Developments
- 8.2 Sandoz
- 8.2.1 Sandoz Comapny Information
- 8.2.2 Sandoz Business Overview
- 8.2.3 Sandoz Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Sandoz Finasteride Product Portfolio
- 8.2.5 Sandoz Recent Developments
- 8.3 Shandong Renhetang Pharmaceutical
- 8.3.1 Shandong Renhetang Pharmaceutical Comapny Information
- 8.3.2 Shandong Renhetang Pharmaceutical Business Overview
- 8.3.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio
- 8.3.5 Shandong Renhetang Pharmaceutical Recent Developments
- 8.4 Merck
- 8.4.1 Merck Comapny Information
- 8.4.2 Merck Business Overview
- 8.4.3 Merck Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Merck Finasteride Product Portfolio
- 8.4.5 Merck Recent Developments
- 8.5 Zhejiang CONBA Pharmaceutical
- 8.5.1 Zhejiang CONBA Pharmaceutical Comapny Information
- 8.5.2 Zhejiang CONBA Pharmaceutical Business Overview
- 8.5.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio
- 8.5.5 Zhejiang CONBA Pharmaceutical Recent Developments
- 8.6 Henan Topfond
- 8.6.1 Henan Topfond Comapny Information
- 8.6.2 Henan Topfond Business Overview
- 8.6.3 Henan Topfond Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 Henan Topfond Finasteride Product Portfolio
- 8.6.5 Henan Topfond Recent Developments
- 8.7 Guangdong Eashu Pharmacetical
- 8.7.1 Guangdong Eashu Pharmacetical Comapny Information
- 8.7.2 Guangdong Eashu Pharmacetical Business Overview
- 8.7.3 Guangdong Eashu Pharmacetical Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio
- 8.7.5 Guangdong Eashu Pharmacetical Recent Developments
- 8.8 RelonChem
- 8.8.1 RelonChem Comapny Information
- 8.8.2 RelonChem Business Overview
- 8.8.3 RelonChem Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.8.4 RelonChem Finasteride Product Portfolio
- 8.8.5 RelonChem Recent Developments
- 8.9 Dr. Reddy
- 8.9.1 Dr. Reddy Comapny Information
- 8.9.2 Dr. Reddy Business Overview
- 8.9.3 Dr. Reddy Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.9.4 Dr. Reddy Finasteride Product Portfolio
- 8.9.5 Dr. Reddy Recent Developments
- 8.10 Cipla
- 8.10.1 Cipla Comapny Information
- 8.10.2 Cipla Business Overview
- 8.10.3 Cipla Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.10.4 Cipla Finasteride Product Portfolio
- 8.10.5 Cipla Recent Developments
- 8.11 Actavis
- 8.11.1 Actavis Comapny Information
- 8.11.2 Actavis Business Overview
- 8.11.3 Actavis Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.11.4 Actavis Finasteride Product Portfolio
- 8.11.5 Actavis Recent Developments
- 8.12 Accord Pharmaceuticals
- 8.12.1 Accord Pharmaceuticals Comapny Information
- 8.12.2 Accord Pharmaceuticals Business Overview
- 8.12.3 Accord Pharmaceuticals Finasteride Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.12.4 Accord Pharmaceuticals Finasteride Product Portfolio
- 8.12.5 Accord Pharmaceuticals Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Finasteride Value Chain Analysis
- 9.1.1 Finasteride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Finasteride Production Mode & Process
- 9.2 Finasteride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Finasteride Distributors
- 9.2.3 Finasteride Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

